**Executive Summary**
This report details the measures implemented by the Ministry of Health and Family Welfare to ensure the efficiency, transparency, and quality of the AMRIT (Affordable Medicines and Reliable Implants for Treatment) pharmacy initiative. Managed by HLL Lifecare Limited, the program focuses on reducing the financial burden for patients with critical ailments through annual statutory audits, automated pricing systems, and direct medicine sourcing. Key reporting channels and monitoring protocols are established to maintain supply chain integrity and address public grievances.
**Key Points / Main Content**
**Operational Framework**
* **Management Model:** AMRIT pharmacies operate under a Company Owned, Company Operated (COCO) model managed by HLL Lifecare Limited, a Government of India Enterprise.
* **Objective:** The initiative serves as a flagship scheme to provide affordable treatment for cancer, cardiovascular diseases, and other critical ailments.
**Monitoring and Compliance**
* **Oversight Protocols:** Outlets are monitored and inspected based on Memorandums of Understanding (MoUs) between HLL Lifecare Limited and respective State Governments or host institutions.
* **Audit Requirements:** Financial and operational performances are subject to mandatory statutory audits on an annual basis.
* **Review Focus:** Inspections prioritize supply chain integrity, stock availability, and the sale of genuine branded medicines.
**Quality Assurance and Transparency**
* **Direct Sourcing:** To ensure the authenticity of branded drugs, medicines are sourced directly from reputed manufacturers or authorized distributors.
* **Automated Pricing:** An integrated IT system is utilized at the point of sale to automatically apply discounts governed by MoUs, minimizing manual intervention.
**Grievance Redressal**
* **Reporting Channels:** A robust mechanism allows patients and attendants to report discrepancies via hospital authorities, a specialized feedback email (amrit_ncc@lifecarehll.com), the HLL Lifecare website, or the CPGRAMS portal.
* **Resolution:** Complaints regarding pricing or service delivery are examined and resolved in a time-bound manner.
**Impact Analysis**
**Patients and Attendants**
**Impact**
They benefit from reduced financial burdens and guaranteed access to authentic, branded medicines at discounted prices. They also gain a transparent platform to report grievances.
**Action Required**
Patients should ensure they receive automated discounts at the point of sale and utilize provided grievance channels if discrepancies in service or pricing occur.
**HLL Lifecare Limited**
**Impact**
As the managing entity, they are responsible for the operational success, supply chain integrity, and adherence to MoU terms across all COCO outlets.
**Action Required**
Must facilitate annual statutory audits, maintain the integrated IT system, and ensure medicines are sourced only from authorized manufacturers or distributors.
**State Governments and Host Institutions**
**Impact**
These entities act as partners in the monitoring and review process of the pharmacy outlets located within their jurisdictions.
**Action Required**
Must conduct regular reviews and inspections of AMRIT outlets in accordance with the signed MoUs to verify stock availability and pricing adherence.
Key Entities Referenced
Affordable Medicines and Reliable Implants for Treatment (AMRIT) initiative: A flagship scheme of the Ministry of Health & Family Welfare aimed at reducing the financial burden on patients suffering from cancer, cardiovascular diseases, and other critical ailments.
HLL Lifecare Limited: A Government of India Enterprise responsible for managing AMRIT pharmacies under a Company Owned, Company Operated (COCO) model and conducting operations via Memorandums of Understanding with State Governments.
Ministry of Health & Family Welfare: The primary central ministry responsible for the oversight, implementation, and reporting on the progress of the AMRIT initiative.
Centralised Public Grievance Redress and Monitoring System (CPGRAMS): A digital portal utilized as part of the scheme's robust grievance mechanism to report and resolve discrepancies regarding service delivery or pricing.
Ministry of Health and Family Welfare
Steps Taken to Ensure Efficiency of AMRIT
Pharmacies
The financial and operational performances of AMRIT
pharmacies are subject to statutory audits on annual basis
AMRIT pharmacies utilize an integrated IT system to ensure
that discounts are automatically applied at the point of sale,
minimizing manual intervention
Medicines are sourced directly from reputed manufacturers
or authorized distributors, ensuring the authenticity of
branded drugs
A robust public grievance mechanism is active, allowing
patients or their attendants to report discrepancies
Posted On: 27 MAR 2026 2:15PM by PIB Delhi
Affordable Medicines and Reliable Implants for Treatment (AMRIT) initiative is a flagship scheme of the
Ministry of Health & Family Welfare aimed at reducing the financial burden on patients suffering from
cancer, cardiovascular diseases, and other critical ailments. AMRIT pharmacies operate under a Company
Owned, Company Operated (COCO) model, managed by HLL Lifecare Limited, a Government of India
Enterprise.
The monitoring, review, and inspection of AMRIT outlets are conducted in accordance with the
Memorandum of Understanding (MoU) signed between HLL Lifecare Limited and the respective State
Governments or host Institutions. These reviews focus on supply chain integrity, adherence to discounted
pricing structures, stock availability and sale of genuine branded medicines at discounted prices. The
financial and operational performances of AMRIT pharmacies are subject to statutory audits on annual basis.
Further, following mechanisms are currently in place in order to ensure transparency and quality
assurance:
• Pricing and discount structures are governed by the terms of the MoU. AMRIT pharmacies utilize
an integrated IT system to ensure that discounts are automatically applied at the point of sale, minimizing
manual intervention.
• Medicines are sourced directly from reputed manufacturers or authorized distributors, ensuring the
authenticity of branded drugs.• A robust public grievance mechanism is active, allowing patients or their attendants to report
discrepancies directly to the hospital authorities or specialized feedback email
(amrit_ncc@lifecarehll.com) or through HLL Lifecare Limited website
(https://www.lifecarehll.com/complaint) or Centralised Public Grievance Redress and Monitoring System
(CPGRAMS) portal. The complaints received regarding service delivery or pricing have been examined
and resolved in a time bound manner.
The Union Minister of State for Health and Family Welfare, Shri Prataprao Jadhav stated this in a written
reply in the Lok Sabha today.
****
SR
HFW/PQ-Steps taken to ensure efficiency of AMRIT Pharmacies/27 March 2026/2
(Release ID: 2245959) Visitor Counter : 110